COVID-19 vaccine approved for trials, says Chinese military
The Chinese Ministry of National Defense (MND) announced on 18 March that a vaccine for the COVID-19 coronavirus, developed by the Academy of Military Medical Sciences of the People’s Liberation Army (PLA), has been approved for clinical trials.
The subunit vaccine has apparently been approved for safe testing on humans by an undisclosed (and therefore unverified) third party.
Preparations for mass production of the vaccine are also under way, the MND stated.
The team of PLA scientists worked under senior bioengineer Maj Gen Chen Wei. He has been conducting research in Wuhan, where the COVID-19 outbreak began.
A subunit vaccination includes a fragment of the pathogen that can initiate an immune response.
More from Defence Notes
NATO Defence Ministers met on 15 February to discuss how to further strengthen the alliance’s deterrence and defence followed by a meeting of the NATO-Ukraine Council.
With the possibility of having to confront challenges without substantial US support looming, European nations have been compelled to reassess their defence strategies and prioritise investments to ensure collective security and resilience.
As part of the national security supplemental package, the fund will now be analysed by the House of Representatives.